The Cuban Strategy for Combatting the COVID-19 Pandemic

Detalhes bibliográficos
Autor(a) principal: Riverol, Amilcar Pérez [UNESP]
Data de Publicação: 2020
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://hdl.handle.net/11449/205158
Resumo: The emerging SARS-CoV-2, a novel human coronavirus, caused the COVID-19 pandemic, with more than 9.5 million cases and 484 000 known fatalities to date (June 24th, 2020). In several regions, healthcare systems have collapsed whereas interventions applied to slow the viral spreading have had major social and economic impacts. After China, Europe, and the United States, Latin America has emerged as the new epicenter of the pandemic. By late-June, the region accounted for roughly 50% of global daily deaths (Gardner, 2020). The evolution of the COVID-19 pandemic in the region has been heterogenous as several countries are currently experiencing exponential growth of their daily cases and fatalities, while others have successfully controlled their corresponding outbreaks. Cuba confi rmed its fi rst COVID-19 cases in mid-March. After a three-month outbreak, the country recently began to move to a postepidemic phase. This dispatch details some relevant aspects of the strategy deployed in Cuba to face the COVID-19 pandemic and to decrease the impact of this emerging disease in the country. In addition, it describes the evolution of some epidemiological variables which allowed the country to de-escalate some of the non-pharmaceutical interventions applied during the outbreak.
id UNSP_3efe1c75b0f2c40f8610026320c16e99
oai_identifier_str oai:repositorio.unesp.br:11449/205158
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling The Cuban Strategy for Combatting the COVID-19 PandemicThe emerging SARS-CoV-2, a novel human coronavirus, caused the COVID-19 pandemic, with more than 9.5 million cases and 484 000 known fatalities to date (June 24th, 2020). In several regions, healthcare systems have collapsed whereas interventions applied to slow the viral spreading have had major social and economic impacts. After China, Europe, and the United States, Latin America has emerged as the new epicenter of the pandemic. By late-June, the region accounted for roughly 50% of global daily deaths (Gardner, 2020). The evolution of the COVID-19 pandemic in the region has been heterogenous as several countries are currently experiencing exponential growth of their daily cases and fatalities, while others have successfully controlled their corresponding outbreaks. Cuba confi rmed its fi rst COVID-19 cases in mid-March. After a three-month outbreak, the country recently began to move to a postepidemic phase. This dispatch details some relevant aspects of the strategy deployed in Cuba to face the COVID-19 pandemic and to decrease the impact of this emerging disease in the country. In addition, it describes the evolution of some epidemiological variables which allowed the country to de-escalate some of the non-pharmaceutical interventions applied during the outbreak.University of Sao Paulo State (UNESP)University of Aarhus (Denmark)University of Giessen-UKGM (Germany)University of Sao Paulo State (UNESP)Universidade Estadual Paulista (Unesp)University of Aarhus (Denmark)University of Giessen-UKGM (Germany)Riverol, Amilcar Pérez [UNESP]2021-06-25T10:10:49Z2021-06-25T10:10:49Z2020-07-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article64-68MEDICC Review, v. 22, n. 3, p. 64-68, 2020.1527-31721555-7960http://hdl.handle.net/11449/2051582-s2.0-85089768648Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengMEDICC Reviewinfo:eu-repo/semantics/openAccess2021-10-23T10:58:38Zoai:repositorio.unesp.br:11449/205158Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462021-10-23T10:58:38Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv The Cuban Strategy for Combatting the COVID-19 Pandemic
title The Cuban Strategy for Combatting the COVID-19 Pandemic
spellingShingle The Cuban Strategy for Combatting the COVID-19 Pandemic
Riverol, Amilcar Pérez [UNESP]
title_short The Cuban Strategy for Combatting the COVID-19 Pandemic
title_full The Cuban Strategy for Combatting the COVID-19 Pandemic
title_fullStr The Cuban Strategy for Combatting the COVID-19 Pandemic
title_full_unstemmed The Cuban Strategy for Combatting the COVID-19 Pandemic
title_sort The Cuban Strategy for Combatting the COVID-19 Pandemic
author Riverol, Amilcar Pérez [UNESP]
author_facet Riverol, Amilcar Pérez [UNESP]
author_role author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
University of Aarhus (Denmark)
University of Giessen-UKGM (Germany)
dc.contributor.author.fl_str_mv Riverol, Amilcar Pérez [UNESP]
description The emerging SARS-CoV-2, a novel human coronavirus, caused the COVID-19 pandemic, with more than 9.5 million cases and 484 000 known fatalities to date (June 24th, 2020). In several regions, healthcare systems have collapsed whereas interventions applied to slow the viral spreading have had major social and economic impacts. After China, Europe, and the United States, Latin America has emerged as the new epicenter of the pandemic. By late-June, the region accounted for roughly 50% of global daily deaths (Gardner, 2020). The evolution of the COVID-19 pandemic in the region has been heterogenous as several countries are currently experiencing exponential growth of their daily cases and fatalities, while others have successfully controlled their corresponding outbreaks. Cuba confi rmed its fi rst COVID-19 cases in mid-March. After a three-month outbreak, the country recently began to move to a postepidemic phase. This dispatch details some relevant aspects of the strategy deployed in Cuba to face the COVID-19 pandemic and to decrease the impact of this emerging disease in the country. In addition, it describes the evolution of some epidemiological variables which allowed the country to de-escalate some of the non-pharmaceutical interventions applied during the outbreak.
publishDate 2020
dc.date.none.fl_str_mv 2020-07-31
2021-06-25T10:10:49Z
2021-06-25T10:10:49Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv MEDICC Review, v. 22, n. 3, p. 64-68, 2020.
1527-3172
1555-7960
http://hdl.handle.net/11449/205158
2-s2.0-85089768648
identifier_str_mv MEDICC Review, v. 22, n. 3, p. 64-68, 2020.
1527-3172
1555-7960
2-s2.0-85089768648
url http://hdl.handle.net/11449/205158
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv MEDICC Review
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 64-68
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1799964383264112640